Biotechnology, one of molecular biology’s branches, monitored and intentional manipulation of biological organisms, processes or systems to effectively make or process drugs, or any other products and substances useful to enhancing people’s living quality. The earliest examples of humans applying their knowledge of biotechnology involved the efforts to enhance plants and animals’ species by cross-pollination (allogamy) or cross-breeding.
Biotechnology has recently turned to a more sophisticated business, considerably enlarged in scale and application range. Having goodly restored from the recession, the world Biotechnology Market is anticipated to be eventually estimated at far over EUR 245 billion by end-2015. However, with the numerous benefits this advanced technology comes laden with, there are worries about its potential misuse. Concerns over this issue has trailed into some attempting to facilitate the enforcement of specific laws constraining or even banning relevant programs and research (e.g. human cloning).
The research reports from this Catalogue offer a comprehensive outlook on the worldwide Biotechnology Market. The reports identify major market challenging forces and growth drivers, provide fresh statistics on the Biotechnology Industry, outline various trends and factors specifying the market’s direction, and more. Regional and country markets’ reviews are at hand in the reports too. Furthermore, companies with their innovations are discussed, and also short to long term forecasts are provided in the researches.
Publications found:
1,342
Sort by:
2014 Market Research Report on Global Cell Culture Flasks Industry
US$ 2,850.00
'2014 Market Research Report on Global Cell Culture Flasks Industry' was a professional and depth research report on Global Cell Culture Flasks industry that ... , cost structure etc. Then we deeply analyzed the world's main region market conditions that including the product price, profit, capacity, production, ...
February 2014
176 pages
Physician Views: Biosimilar naming conventions – what do physicians think?
US$ 695.00
... what do physicians think? What do they consider to be the correct naming convention and how will this impact their potential usage of biosimilars. This week's Physician Views poll will ask US and EU5-based oncologists and rheumatologists: What naming convention for biosimilar products they believe ...
February 2014
India Cord Blood Stem Cell Banking Market
US$ 600.00
... in India. Till date around six major private players, both Indian as well subsidiaries of international companies are operating in the stem cell banking market of India. “India Cord Blood Stem Cell Banking Market” research report outlines following aspects related to booming stem cell banking in India: India Stem Cell Research & Therapy Market Overview Cord Blood Stem Cell Banking ...
February 2014
58 pages
Global EPO Biosimilars Market Outlook 2018
US$ 400.00
... governments and private players worldwide stepping into this industry, the market shows bright prospects and immense opportunities to cash in on. As per the estimations of our latest report, “Global EPO Biosimilars Market Outlook 2018”, the global EPO biosimilars market will grow at a CAGR of around 37% ...
January 2014
45 pages
Physician Views: How do Indian oncologists plan to use biosimilar Herceptin?
US$ 695.00
... to drive a notable shift in the Indian trastuzumab market, this week's Physician Views poll asks Indian oncologists to provide their initial views on what its availability will ... drug) or across the HER2-positive breast cancer treatment paradigm? How confident they are in using CANMAb given the relative size ...
January 2014
Global Stem Cell Umbilical Cord Blood (UCB) Market (Storage Service, Therapeutics, Application, Geography) - Size, Share, Global Trends, Analysis, Opportunities, Growth, Intelligence and Forecast, 2012 - 2020
US$ 4,515.00
Umbilical cord blood stem cells are potential stem cells that can convert into any type of -determined cells. Global stem cell market ... transplant Transplant Medicine Regenerative Medicine Others Cord Blood Banking Blood Transfusion Cell Based Genetics Global Stem cell UCB market by Geography UCB market ...
January 2014
148 pages
South Korea Biosimilar Market Analysis
US$ 800.00
... of the global market for biosimilars by 2020. “South Korea Biosimilar Market Analysis” reports gives comprehensive details on following aspects related to Biosimilar development in South Korea: Market Overview Favorable Market Parameters Biosimilar Pipeline Analysis by Company, Phase ...
January 2014
110 pages
Global Monoclonal Antibodies Pipeline Analysis
US$ 1,800.00
... when purchasing Hard Copy License depending on the location. The market for monoclonal antibodies (mAB) has become the fastest growing segment ... for each orphan designated drug profile in development phase are covered in “Global Monoclonal Antibodies Pipeline Analysis” research report: Drug Profile Overview ...
January 2014
1360 pages
Biological Machines Trends: Market Research Report
US$ 950.00
The report illustrates about the recent advances in the engineering technology assisting in the development of biological machines with mechanical and electrical sensors. 'Biological machines (also known as a cellular system) can be defined as cellular devices designed to carry out certain functions such as ...
December 2013
5 pages
Biomimetics Trends: Market Research Report
US$ 950.00
... disciplines for benefiting humans in improving their health and quality of life. The report analyzes and presents an overview of Biomimetics market worldwide. The report also provides a review of trends, growth drivers, and strategic industry activities of major companies worldwide. ...
December 2013
10 pages
Biosimulation Trends: Market Research Report
US$ 950.00
... from experiments during drug discovery and development. The report analyzes and presents an overview of Biosimulation market worldwide. The report provides global market ... in US dollars for the years 2012 through 2017. Supported with 1 market data table, the report highlights the ever increasing permanence of ...
December 2013
11 pages
Immunoassay Market [Technology (Enzyme, Fluorescent, Chemiluminescence, Radioimmunoassay), Analyzers & Reagents, Applications (Infectious Diseases, Cancer, Endocrinology, Cardiology), End Users (Hospitals, Laboratory, Academics)] – Global Forecast to 2018
US$ 5,650.00
... scenario. The global immunoassay market is segmented as follows: By Technology: Enzyme Immunoassay (EIA) Fluorescent Immunoassay Chemiluminescence Immunoassay (CLIA) Radioimmunoassays (RIA) Others (Nephelometric Immunoassay, Turbidimetric Immunoassay, and Counting Immunoassay (CIA)) By Application: Oncology ...
November 2013
315 pages
European Markets for Orthopedic Biomaterials
US$ 8,995.00
... biomaterials market is expected to reach €376.7 million by 2019, with hyaluronic acid viscosupplementation as the largest segment. The European orthopedic biomaterials market includes bone graft substitutes (BGS), hyaluronic acid (HA) viscosupplementation, bone morphogenetic protein (BMP) growth factor ...
October 2013
328 pages
Commercialisation of Biosimilars: strategies for market penetration
US$ 595.00
... world in biosimilar sales. Although the European experience differs markedly from the anticipated evolution of biosimilars in the US, there are lessons to be learned. In Commercialisation of Biosimilars: strategies for ... of how to design strategies to influence key opinion leaders Understand why biosimilar acceptance is slower than most new generic drugs Commercialisation of Biosimilars: strategies for market penetration ...
October 2013
124 pages
Generics/Biosimilars Collection
US$ 4,595.00
The collection includes the following reports: Charting the Biosimilar and Biobetter Development Pipeline (2013) Biosimilar Defensive Plays - assessing the options Branded Generics: Strategies and Tactics for Winning in Latin America Biosimilars in Emerging Markets (Volume 1 and Volume 2)
October 2013
Therapy Class Overview: Rituximab biosimilar
US$ 2,000.00
... emerging market experience in India and Mexico. Rituximab biosililar pipeline, and the current status of clinical development What are the Innovator's strategy in protecting rituximab franchise? Competition to biosimilar rituximab ...
October 2013
45 pages
Competitor Analysis: PTH Receptor Agonists, Teriparatide Biosimilars and Biosuperiors
US$ 265.00
... of proteins and peptides as agonists of the parathyroid hormone (PTH) receptor. In addition, the report lists company-specific R&D pipelines of PTH receptor agonists. Competitor projects are listed in a tabular format providing information on: Drug Codes, Target / Mechanism of Action, Class of Compound, ...
October 2013
33 pages
Global Cell Therapy Pipeline Analysis
US$ 1,500.00
... Therapy. Research report covers all the ongoing drug development in various development phases. Each drug profiles include detailed information like: Originator, ... parameters for each drug profile in development phase are covered in “Global Cell Therapy Pipeline Analysis” research report: Drug Profile Overview ...
September 2013
220 pages
U.S. Market for Orthopedic Biomaterials
US$ 6,995.00
... Drivers & Limiters Mergers & Acquisitions Customer Feedback and Market Monitoring The orthopedic biomaterials market has seen movement and reallocation of interests ... soft tissue usage, has more than made up for a slowing spinal market segment. As there continues to be more clinical trials for platelet-rich ...
August 2013
273 pages
Directory of US Biotechnology Companies-Excel Format
US$ 197.00
The USA Directory of Biotechnology Companies 2014 is a comprehensive Excel Directory of companies and executives in the biotechnology industry. It contains contact information for more than 1,300 biotechnology companies. This powerful Directory is your connection to key decision-makers in the biotechnology ...
August 2013
255 pages
Stem Cell Technologies: World Market Outlook 2013-2023
US$ 2,635.00
... cell transplantation (HSCT) Uses for umbilical cord blood and related technologies Supply, storage (banking) and processing of the cellular material. That ... activities, results, R&D, and outlooks for future success. Stem Cell Technologies: World Market Outlook 2013-2023 gives independent analysis. There ...
August 2013
151 pages
Research Report on Global and China Monoclonal Antibody Industry, 2013-2017
US$ 2,200.00
... the development of biological drugs in the next few years. In recent years, China bio-pharmaceuticals industry develops rapidly, but antibody drugs lag ... products in the future. Monoclonal antibody still belongs to high-end products in China market, which mainly depends on import. In 2012, the market scale ...
August 2013
50 pages
China Biopharmaceuticals Market Report
US$ 680.00
This report presents a clear picture about the overall development of biopharmaceuticals market in China and the trend in recent years based on detailed data ... and the value of imports... The report offers data on the market shares of imported products, foreign enterprises and enterprises in other forms. It ...
July 2013
49 pages
Biomarkers: Technological and Commercial Outlook 2013-2023
US$ 2,635.00
... Services. You see, too, world revenues to 2023 divided into technological disciplines: Genomics Proteomics Bioinformatics Other applications. You also find ... you stay ahead. Information found nowhere else Biomarkers: Technological and Commercial Outlook 2013-2023 gives independent analysis. There you ...
July 2013
178 pages
Biosimilar Monoclonal Antibodies: World Market Prospects 2013-2023
US$ 2,635.00
... ten medicines worldwide by revenue. For those therapies, high potential for biosimilar competition exists. Our analysis predicts those competitors of the leading ... the possibilities, helping you stay ahead. Nine ways Biosimilar Monoclonal Antibodies: World Market Prospects 2013-2023 helps you To sum up, our ...
July 2013
150 pages
Charting the Biosimilar and Biobetter Development Pipeline (2013)
US$ 1,950.00
... , losing patent expiry in the coming years the potential for biosimilars remains high. With greater clarity on regulatory approval and the ... ) comes in. Scope Charting the Biosimilar and Biobetter Development Pipeline (2013) will help you to: Understand the landscape of biosimilar/biobetter development ...
June 2013
China Artificial Limb & Man-made Organs Mfg. Industry Profile - CIC3586
US$ 580.00
... provides key data and concise analyses on the artificial limb & man-made organs mfg. industry in China, a list of major 20 enterprises in the sector ... on distribution of and difference in performance in regions of Mainland China in terms of the artificial limb & man-made organs mfg. industry; To figure out the ...
June 2013
24 pages
Global Bioinformatics Market Forecast to 2017
US$ 1,400.00
... on the back of rising genomics industry. In their latest research study, “Global Bioinformatics Market Forecast to 2017”, RNCOS’ analysts identified that the ... growth and future directions. In addition, the market has witnessed the launches of key bioinformatics products and services in various areas, and we ...
May 2013
110 pages
US Nutraceuticals Market Forecast to 2017
US$ 1,000.00
... growth. In RNCOS’ latest research study, “US Nutraceuticals Market Forecast to 2017”, RNCOS analysts identified and deciphered the market dynamics in important segments to clearly ... the reader to gain a deeper insight into each key market player. Moreover, market drivers and trends have been discussed along ...
May 2013
100 pages
Biosimilar Defensive Plays - Assessing the options
US$ 495.00
... . This insightful report brings you completely up to date with the biosimilar competitive landscape, and gives you the information you need ... .” Warwick Smith, director-general, British Generic Manufacturers Association Biosimilar Defensive Plays - assessing the options is designed to answer your strategic and ...
May 2013
87 pages
China Biopharmaceuticals Mfg. Industry Profile - CIC2760
US$ 580.00
... investment environment in top 10 hot regions. In addition, the report truly reflects the position of foreign enterprises in biopharmaceuticals mfg. industry across China based on a comprehensive comparison of operating conditions among different enterprise types. This report includes the data for the year ...
May 2013
28 pages
Competitor Analysis: Therapeutic Proteins – Biosimilars, Biobetters & Biosuperiors
US$ 2,100.00
The new Competitive Intelligence Report Therapeutic Proteins – Biosimilars, Biobetters & Biosuperiors of May 2013 provides a competitor analysis in the product portfolios and development pipelines of ten major classes of therapeutic proteins and their biosimilar and biobetter/biosuperior versions in regulated ...
May 2013
301 pages
Biosimilars And Follow-On Biologics: World Market 2013-2023
US$ 2,635.00
... other aspects of the field, including these: Developments in technology to aid biosimilar production Incidence and prevalence of diseases affecting demand for the ... those substitutes, helping you stay ahead. Nine ways Biosimilars and Follow-On Biologics: World Market 2013-2023 helps you In particular, then ...
April 2013
235 pages
Cell Culture: The Market for Media, Sera and Reagents, 5th Edition
US$ 3,995.00
... currently employed and emerging in the cell culture area, Kalorama's exhaustive report provides specific information on: Market Size, growth, and forecasts ... Discussion of the preferences in media types vying for dominance in the market, including the following: ADCF - animal derived component free media ...
April 2013
152 pages
India Stem Cell Banking Market Analysis
US$ 500.00
... in the stem cell banking market of India. “India Stem Cell Banking Market Analysis” research report outlines following aspects related to booming stem cell banking in India: India Stem Cell Research & Therapy Market Overview Stem Cell Banking Market Overview Cord Blood & Menstrual Banking Cost Analysis ...
April 2013
55 pages
Biobanking For Medicine: Technology And Market 2013-2023
US$ 2,635.00
... -temperature storage Energy conservation in biorepositories Consumables, RFID and tagging technologies Automated storage and retrieval systems for operational efficiency Software ... its prospects, helping you stay ahead. Eight ways Biobanking for Medicine: Technology and Market 2013-2023 helps you To sum ...
March 2013
158 pages
Antibody Technologies and Attrition Rates - an Industry Analysis 2013
US$ 2,765.00
... legal literature. The report provides descriptive statistics of the 504 naked antibodies and their status during the study period of January 1, 2013 to ... the different in vitro and in antibody generation technologies. Attrition rate was defined as the percentage of failed antibodies of all active and inactive ...
March 2013
607 pages
Next-Generation Antibody Therapeutics Market 2013-2023
US$ 2,635.00
... (mAbs) and other immunotechnology. See forecasted sales at overall world market and submarket level. Also assess emerging trends and expected ... technological and commercial possibilities. Eight ways Next-Generation Antibody Therapeutics Market 2013-2023 helps In particular, then, our investigation gives ...
February 2013
164 pages
Therapeutic Class Report Overview - Rituxan Biosimilar
US$ 2,000.00
The growth in the biosimilar opportunity will be driven by several patent expiries of mega-blockbuster biologics in the next 5 years. Between 2012 and 2017, over $60b worth of sales of biologics in the US/EU will lose patent protection. Out of them, Roche’s/Biogen Idec’s Rituxan/MabThera (rituximab), Merck ...
February 2013
45 pages
Latin American Markets for Dental Bone Graft Substitutes and Other Biomaterials
US$ 7,995.00
... membranes is expected to grow at a CAGR of 17.1% by 2019. The total Latin American dental market for bone graft substitute and other biomaterials increased ... segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “bottom up” approach, which includes primary and ...
January 2013
162 pages
Therapeutic Class Report Overview - Japan Biosimilars
US$ 1,000.00
... forces as compared to generics, a number of companies aim to exploit this – Japan has seen a flood like consolidation and partnering activities in biosimilar ... , Yoshindo etc. to be amongst the key players in biogenerics business in Japan. In this piece, we attempt to evaluate the future competitive landscape of ...
January 2013
32 pages
Global Transfection (Gene Delivery, DNA Delivery, Protein Delivery, SiRNA Delivery) Technologies (Lipofection, Calcium Phosphate, Electroporation, Nucleofection, Magnetofection, Gene Gun, Viral) Market (2012 – 2017)
US$ 5,650.00
... cell lines, gene therapy, delivery of therapeutics and also drug discovery. This research report provides a brief description on transfection technologies, its ... Roche, Polyplus Transfection, Mirius Bio, Maxcyte, etc. SCOPE OF THE REPORT A comprehensive analysis of the market size and global revenue has ...
December 2012
130 pages
Indian Stem Cell Banking Market: Trends & Opportunities (2012-2017)
US$ 700.00
... rates of stem cell banking ranging from 15% to 30%. Regions such as, US, Europe, China and India have low penetration ... stem cells from embryos. The report titled ‘Indian Stem Cell Banking Market: Trend and Opportunities (2012-2017)’ provides an in-depth analysis of the Indian stem cell banking market ...
November 2012
54 pages
Innovative Hematology and Flow Cytometry Technologies and Emerging Markets
US$ 22,720.00
... potential market entrants identify and evaluate emerging opportunities in the hematology and flow cytometry markets during the next ten years. The ... forces regulating systemic diseases, will have a profound impact on the hematology and flow cytometry markets worldwide. New molecular diagnostic and monoclonal ...
November 2012
700 pages
China Biological & Biochemical Products Market Report
US$ 680.00
... and number of employees, the report shows their market positions in China. Additionally, this report lists basic contact information of the top ... the structure and concentration ratio of the current biological & biochemical products market in China by means of Bain's Market Structure Classification and Index ...
October 2012
50 pages
